Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
The method sheet of elecsys dhea-s for cobas e 411 cobas e 601 cobas e 602 and modular analytics e systems has been updated for several changes and the revised method sheet now contains the following information: no interference was observed from rheumatoid factors up to a concentration of 80 iu/ml.